Next generation sequencing for preimplantation genetic testing of blastocysts aneuploidies in women of different ages

被引:11
作者
Lukaszuk, Krzysztof [1 ,2 ]
Jakiel, Grzegorz [1 ,3 ]
Kuczynski, Waldemar [4 ,5 ]
Pukszta, Sebastian [1 ]
Liss, Joanna [1 ]
Plociennik, Lukasz [1 ]
Lukaszuk, Aron [1 ]
Pastuszek, Ewa [1 ]
机构
[1] Invicta Fertil & Reprod Ctr, Wroclaw, Poland
[2] Med Univ Gdansk, Dept Obstet & Gynecol Nursing, Fac Hlth Sci, Gdansk, Poland
[3] Med Ctr Postgrad Educ, Dept Obstet & Gynaecol, Warsaw, Poland
[4] Med Univ Bialystok, Dept Gynecol & Oncol Gynecol, Bialystok, Poland
[5] KRIOBANK, Ctr Reprod Med, Bialystok, Poland
关键词
Preimplantation genetic diagnosis (PGD); next generation sequencing (NGS); blastocyst; IN-VITRO FERTILIZATION; CHROMOSOMAL-ABNORMALITIES; EMBRYO DEVELOPMENT; LIVE BIRTH; DIAGNOSIS; TECHNOLOGY; MORPHOLOGY; SELECTION; IMPACT;
D O I
10.5604/12321966.1196874
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Most of the current preimplantation genetic screening of aneuploidies tests are based on the low quality and low density comparative genomic hybridization arrays. The results are based on fewer than 2,700 probes. Our main outcome was the association of aneuploidy rates and the women's age. Between August-December 2013, 198 blastocysts from women (mean age 36.3+-4.6) undergoing in vitro fertilization underwent routine trophectoderm biopsy. NGS was performed on Ion Torrent PGM (Life Technologies). The results were analyzed in five age groups (<31, 31-35, 36-38, 39-40 and >40). 85 blastocysts were normal according to NGS results. The results in the investigated groups were (% of normal blastocyst in each group): <31 (41.9%), 31-35 (47.6%), 36-38 (47.8%), 39-40 (37.7%) and >40 (38.5%). Our study suggests that NGS PGD is applicable for routine preimplantation genetic testing. It allows also for easy customization of the procedure for each individual patient making personalized diagnostics a reality.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 17 条
[1]   The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender [J].
Alfarawati, Samer ;
Fragouli, Elpida ;
Colls, Pere ;
Stevens, John ;
Gutierrez-Mateo, Cristina ;
Schoolcraft, William B. ;
Katz-Jaffe, Mandy G. ;
Wells, Dagan .
FERTILITY AND STERILITY, 2011, 95 (02) :520-524
[2]   Aneuploidy and early human embryo development [J].
Ambartsumyan, Gayane ;
Clark, Amander T. .
HUMAN MOLECULAR GENETICS, 2008, 17 :R10-R15
[3]   Pronuclear morphology and chromosomal abnormalities as scoring criteria for embryo selection [J].
Gianaroli, L ;
Magli, MC ;
Ferraretti, AP ;
Fortini, D ;
Grieco, N .
FERTILITY AND STERILITY, 2003, 80 (02) :341-349
[4]   24-chromosome copy number analysis: a comparison of available technologies [J].
Handyside, Alan H. .
FERTILITY AND STERILITY, 2013, 100 (03) :595-602
[5]  
Józwiak A, 2013, GINEKOL POL, V84, P682
[6]   Frequency and distribution of chromosome abnormalities in human oocytes [J].
Kuliev, A ;
Cieslak, J ;
Verlinsky, Y .
CYTOGENETIC AND GENOME RESEARCH, 2005, 111 (3-4) :193-198
[7]   Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles [J].
Lukaszuk, K ;
Liss, J ;
Lukaszuk, M ;
Maj, B .
FERTILITY AND STERILITY, 2005, 83 (05) :1372-1376
[8]   Anti-Mullerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology [J].
Lukaszuk, Krzysztof ;
Liss, Joanna ;
Kunicki, Michal ;
Jakiel, Grzegorz ;
Wasniewski, Tomasz ;
Woclawek-Potocka, Izabela ;
Pastuszek, Ewa .
REPRODUCTIVE BIOLOGY, 2014, 14 (03) :176-181
[9]   Probability of live birth in women with extremely low anti-Mullerian hormone concentrations [J].
Lukaszuk, Krzysztof ;
Kunicki, Michal ;
Liss, Joanna ;
Bednarowska, Alicja ;
Jakiel, Grzegorz .
REPRODUCTIVE BIOMEDICINE ONLINE, 2014, 28 (01) :64-69
[10]   Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization [J].
Lukaszuk, Krzysztof ;
Kunicki, Michal ;
Liss, Joanna ;
Lukaszuk, Mariusz ;
Jakiel, Grzegorz .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 168 (02) :173-177